Verrica Pharmaceuticals

NASDAQ: VRCA
Nasdaq Stock Market
Healthcare Biotechnology
Global Rank
#28509
Country Rank
#4008
Market Cap
61.14 M
Price
6.61
Change (%)
0.00%
Volume
134,514

Verrica Pharmaceuticals's latest marketcap:

61.14 M

As of 07/26/2025, Verrica Pharmaceuticals's market capitalization has reached $61.14 M. According to our data, Verrica Pharmaceuticals is the 28509th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 61.14 M
Revenue (ttm) 7.18 M
Net Income (ttm) -65,990,000
Shares Out 9.25 M
EPS (ttm) -10.33
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 08/13/2025
Market Cap Chart
Data Updated: 07/26/2025

Verrica Pharmaceuticals's yearly market capitalization.

Verrica Pharmaceuticals has seen its market value drop from $209.43 M to $61.14 M since 2018, representing a total decrease of 70.81% and an annual compound decline rate (CAGR) of 17.09%.
Date Market Cap($) Change (%) Global Rank
07/26/2025 $61.14 M 2.13% 28509
12/31/2024 $63.4 M -79.41% 26325
12/29/2023 $307.91 M 172.47% 16289
12/30/2022 $113.01 M -55.17% 21489
12/31/2021 $252.07 M -15.33% 17494
12/31/2020 $297.71 M -27.31% 14611
12/31/2019 $409.57 M 95.57% n/a
12/31/2018 $209.43 M n/a

Company Profile

Verrica Pharmaceuticals was founded in 2013 in United States. The company went public on 06/15/2018 on the Nasdaq Stock Market. With 71 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.

Frequently Asked Questions

  • What is Verrica Pharmaceuticals's (VRCA) current market cap?
    As of 07/26/2025, Verrica Pharmaceuticals (including the parent company, if applicable) has an estimated market capitalization of $61.14 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Verrica Pharmaceuticals global market capitalization ranking is approximately 28509 as of 07/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.